ReposiTrak (TRAK) AI Stock Analysis

• Market Cap: $252.20M
• Dividend Yield: 0.56%
• Average Volume (3M): 62.70K
• Price to Earnings (P/E): 38.2
• Beta (1Y): 1.46
• Revenue Growth: 11.05%
• EPS Growth: 18.55%
• Country: US
• Employees: 73
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Application
• EPS (TTM): 0.09
• Shares Outstanding: 18,288,454
• 10 Day Avg. Volume: 63,906
• 30 Day Avg. Volume: 62,699
• PEG Ratio: 2.57
• Price to Book (P/B): 7.25
• Price to Sales (P/S): 15.87
• P/FCF Ratio: 42.70
• Enterprise Value/Market Cap: 1.01
• Enterprise Value/Revenue: 11.03
• Enterprise Value/Gross Profit: 13.11
• Enterprise Value/Ebitda: 29.33
• 1Y Price Target: $29.00
• Price Target Upside: 116.42% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): 0.4
• Revenue Forecast (FY): $24.87M

• Rating: 73 Outperform
• Price Target: $15.00 ▲(11.94% Upside)

ReposiTrak's overall stock score of 73 reflects its strong financial performance and positive earnings call outlook, which are the most significant factors. The technical analysis indicates a bearish trend, which slightly offsets the positive aspects. The valuation is moderate, with a relatively high P/E ratio balanced by a reasonable dividend yield. Corporate events further enhance the score by demonstrating strategic capital management and shareholder value return.

Positive Factors

Strong Financial Health

ReposiTrak's low leverage and efficient cash flow management indicate a stable financial structure, supporting sustainable growth and resilience.

Revenue Growth

Consistent revenue growth demonstrates expanding market reach and product adoption, reinforcing ReposiTrak's competitive position.

Competitive Position

Dominance in traceability and food safety strengthens ReposiTrak's market position, offering a durable competitive advantage.

Negative Factors

Reduced Cash from Operations

Declining cash from operations could constrain future investments and operational flexibility, impacting long-term growth prospects.

Increased Operating Expenses

Rising operating expenses may pressure margins and reduce profitability, challenging ReposiTrak's cost management efforts.

Higher Effective Tax Rate

An increased tax rate could reduce net income and cash flow, potentially impacting ReposiTrak's financial flexibility and shareholder returns.

ReposiTrak Business Overview & Revenue Model

Company Description

ReposiTrak, Inc., a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers. It also provides ScoreTracker, Vendor Managed Inventory, Store Level Ordering and Replenishment, Enterprise Supply Chain Planning, Fresh Market Manager, Audit Management, and ActionManager supply chain solutions to manage inventory, product mix, and labor. In addition, the company offers business-consulting services to suppliers and retailers in the grocery, convenience store, and specialty retail industries, as well as professional consulting services. It primarily serves multi-store retail chains, wholesalers and distributors, and their suppliers. The company was formerly known as Park City Group, Inc. and changed its name to ReposiTrak, Inc. in December 2023. ReposiTrak, Inc. is headquartered in Murray, Utah.

How the Company Makes Money

ReposiTrak generates revenue through a subscription-based model, where clients pay for access to its software platform and services. Key revenue streams include annual subscriptions for compliance and traceability solutions, transaction fees from the processing of product data, and consulting services aimed at helping businesses optimize their supply chain processes. Additionally, partnerships with major retailers and food industry stakeholders enhance revenue opportunities through shared compliance initiatives and data analytics services, allowing ReposiTrak to expand its market reach and strengthen its service offerings.

ReposiTrak Financial Statement Overview

Summary

ReposiTrak exhibits strong financial health with robust profitability, low leverage, and efficient cash flow management. The company is well-positioned for continued growth in the software application industry, supported by its high margins and stable financial structure. While free cash flow growth has seen a slight decline, overall financial performance remains strong, indicating a well-managed and financially sound company.

Income Statement

ReposiTrak demonstrates strong profitability with a high gross profit margin of 83.7% and a solid net profit margin of 30.9% in the TTM. Revenue growth is positive, albeit modest at 2.3% TTM, indicating steady expansion. The company maintains a healthy EBIT margin, although the TTM figure is not available, historical data shows consistent performance. Overall, the income statement reflects robust profitability and stable growth.

Balance Sheet

The balance sheet is strong with a low debt-to-equity ratio of 0.01, indicating minimal leverage and financial risk. Return on equity is healthy at 14.5% TTM, showcasing efficient use of equity capital. The equity ratio stands at 90.2%, reflecting a solid capital structure with a high proportion of equity financing. Overall, the balance sheet is stable with low leverage and effective equity utilization.

Cash Flow

Cash flow analysis shows a slight decline in free cash flow growth at -4.1% TTM, but the company maintains a strong operating cash flow to net income ratio of 1.52, indicating good cash generation relative to earnings. The free cash flow to net income ratio is nearly 1, suggesting efficient conversion of earnings to cash. Despite the decline in free cash flow growth, cash flow metrics remain solid overall.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	23.14M	22.61M	20.45M	19.10M	18.05M	21.01M
Gross Profit	19.46M	18.92M	17.04M	15.79M	14.86M	13.10M
EBITDA	8.70M	8.95M	7.61M	7.11M	5.38M	5.41M
Net Income	7.13M	6.98M	5.96M	5.59M	4.00M	4.12M
Balance Sheet
Total Assets	55.61M	55.33M	51.60M	50.58M	49.32M	55.05M
Cash, Cash Equivalents and Short-Term Investments	28.79M	28.57M	25.15M	23.99M	21.46M	24.07M
Total Debt	457.30K	509.97K	545.10K	747.11K	2.97M	6.70M
Total Liabilities	5.44M	5.81M	4.74M	4.70M	6.42M	9.91M
Stockholders Equity	50.17M	49.52M	46.85M	45.88M	42.90M	45.14M
Cash Flow
Free Cash Flow	8.06M	8.40M	6.89M	7.96M	6.05M	5.08M
Operating Cash Flow	8.09M	8.42M	6.96M	8.86M	6.10M	5.40M
Investing Cash Flow	-54.28K	169.00	-100.71K	-903.19K	1.32M	-318.87K
Financing Cash Flow	-5.03M	-5.01M	-5.70M	-5.43M	-10.03M	-1.36M

ReposiTrak Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 13.40
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TRAK, the sentiment is Negative. The current price of 13.4 is below the 20-day moving average (MA) of 13.61, below the 50-day MA of 14.43, and below the 200-day MA of 17.98, indicating a bearish trend. The MACD of -0.31 indicates Negative momentum. The RSI at 40.88 is Neutral, neither overbought nor oversold. The STOCH value of 65.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TRAK.

ReposiTrak Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TRAK	73 Outperform	$252.20M	38.24	14.60%	0.56%	11.05%	18.55%
MKTW	66 Neutral	$259.19M	1.55	―	13.11%	-19.17%	308.81%
SMRT	62 Neutral	$391.65M	-5.80	-25.48%	―	-24.30%	-181.62%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
ONTF	59 Neutral	$256.23M	―	-20.20%	―	-6.23%	28.57%
FRGE	48 Neutral	$614.25M	―	-28.65%	―	16.40%	22.80%
EGHT	48 Neutral	$303.62M	―	-4.88%	―	0.25%	92.10%

ReposiTrak Corporate Events

ReposiTrak Announces New Share Repurchase Program

On December 4, 2025, ReposiTrak announced that its Board of Directors approved a new 10B5-1 share repurchase program, allowing the company to buy back up to $2 million of its common stock. This initiative is part of a larger $21 million repurchase program, with $7.6 million still available for repurchase. The 10B5-1 plan is a strategic move to optimize capital allocation, facilitating the repurchase and retirement of common shares, alongside other initiatives like redeeming preferred shares and paying dividends.

ReposiTrak Holds Annual Stockholders Meeting

On November 19, 2025, ReposiTrak, Inc. held its Annual Meeting of Stockholders where several key proposals were voted on. The election of directors resulted in the re-election of all nominees, and stockholders approved the executive compensation on a non-binding advisory basis. Additionally, it was decided that the advisory vote on executive compensation will occur every three years, and Haynie & Company was ratified as the independent auditor for the fiscal year ending June 30, 2026.

ReposiTrak Reports Strong Q1 Revenue and Earnings Growth

ReposiTrak reported a 10% increase in revenue to $6.0 million for the first fiscal quarter ending September 30, 2025, with a 13% rise in earnings per share. The company maintained a strong financial position with $29 million in cash and no debt, while also increasing its quarterly dividend by 10%. The company’s focus on automation and operational efficiency is expected to support smaller market participants and enhance profitability, strengthening its competitive position in the traceability and compliance market.

ReposiTrak Reports Strong Financial Year-End Results

ReposiTrak reported a successful fiscal year ending June 30, 2025, with an 11% increase in full-year revenue to $22.6 million and a 17% rise in net income to $7.0 million. The company has shifted its strategy to a supplier-centric model, enhancing engagement with individual suppliers and expanding cross-selling opportunities, which has contributed to its revenue growth and improved financial metrics, such as a 24% increase in operating income. ReposiTrak ended the year with $28.6 million in cash and no debt, and announced a 10% increase in its quarterly dividend, reflecting strong financial health and a commitment to returning capital to shareholders.

ReposiTrak Announces Quarterly Dividend Increase

On September 19, 2025, ReposiTrak, Inc. announced a quarterly cash dividend of $0.02 per share, payable on November 14, 2025, to shareholders of record as of September 30, 2025. This marks the third increase in the company’s dividend since its establishment, reflecting ReposiTrak’s ongoing commitment to returning value to its shareholders.